Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - VALEANT PHARMACEUTICALS INTERNATIONAL | Financial_Report.xls |
| 10-Q - FORM 10-Q - VALEANT PHARMACEUTICALS INTERNATIONAL | a56182e10vq.htm |
| EX-15.2 - EX-15.2 - VALEANT PHARMACEUTICALS INTERNATIONAL | a56182exv15w2.htm |
| EX-15.1 - EX-15.1 - VALEANT PHARMACEUTICALS INTERNATIONAL | a56182exv15w1.htm |
| EX-31.2 - EX-31.2 - VALEANT PHARMACEUTICALS INTERNATIONAL | a56182exv31w2.htm |
| EX-31.1 - EX-31.1 - VALEANT PHARMACEUTICALS INTERNATIONAL | a56182exv31w1.htm |
Exhibit 32
Certification pursuant to 18 U.S.C. Section 1350,
As adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
As adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
Pursuant to 18 U.S.C. Section 1350, each of the undersigned officers of Valeant
Pharmaceuticals International hereby certifies, to the best of such officer’s knowledge, that:
1. The Registrant’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2010 (the
“Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities
Exchange Act of 1934, as amended, and
2. The information contained in the Report fairly presents, in all material respects, the
financial condition and results of operations of the Registrant.
/s/ J. Michael Pearson
J. Michael Pearson
Chairman and Chief Executive Officer
Chairman and Chief Executive Officer
Date:
August 3, 2010
/s/ Peter J. Blott
Peter J. Blott
Executive Vice President and Chief Financial Officer
Executive Vice President and Chief Financial Officer
Date:
August 3, 2010
A signed original of this written statement required by Section 906 has been provided to
Valeant Pharmaceuticals International and will be furnished to the Securities and Exchange
Commission or its staff upon request.